Literature DB >> 14719845

Gynecologic consequences of bacterial vaginosis.

Jane R Schwebke1.   

Abstract

BV is a prevalent sexually associated infection linked to several gynecologic complications and acquisition of STDs and acquisition and transmission of HIV. It seems that normalization of the vaginal flora may be effective for preventing short-term complications. The implications of screening and treating BV to prevent long-term complications are less clear and may depend on the availability of more effective treatment regimens.

Entities:  

Mesh:

Year:  2003        PMID: 14719845     DOI: 10.1016/s0889-8545(03)00086-x

Source DB:  PubMed          Journal:  Obstet Gynecol Clin North Am        ISSN: 0889-8545            Impact factor:   2.844


  21 in total

Review 1.  Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective.

Authors:  Rebecca M Brotman
Journal:  J Clin Invest       Date:  2011-12-01       Impact factor: 14.808

2.  Evaluation of a rapid Gram stain interpretation method for diagnosis of bacterial vaginosis.

Authors:  I Hilmarsdóttir; G S Hauksdóttir; J D Jóhannesdóttir; T Daníelsdóttir; H Thorsteinsdóttir; J H Olafsson
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

3.  DNase inhibits Gardnerella vaginalis biofilms in vitro and in vivo.

Authors:  Saul R Hymes; Tara M Randis; Thomas Yang Sun; Adam J Ratner
Journal:  J Infect Dis       Date:  2013-02-19       Impact factor: 5.226

4.  Polyethylene glycol-based hydrogels for controlled release of the antimicrobial subtilosin for prophylaxis of bacterial vaginosis.

Authors:  Sujata Sundara Rajan; Veronica L Cavera; Xiaoping Zhang; Yashveer Singh; Michael L Chikindas; Patrick J Sinko
Journal:  Antimicrob Agents Chemother       Date:  2014-02-24       Impact factor: 5.191

Review 5.  The vaginal microbiome: new information about genital tract flora using molecular based techniques.

Authors:  R F Lamont; J D Sobel; R A Akins; S S Hassan; T Chaiworapongsa; J P Kusanovic; R Romero
Journal:  BJOG       Date:  2011-01-20       Impact factor: 6.531

6.  The laboratory diagnosis of bacterial vaginosis.

Authors:  Deborah Money
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-03       Impact factor: 2.471

7.  Gardnerella vaginalis: Still a Prime Suspect in the Pathogenesis of Bacterial Vaginosis.

Authors:  C A Muzny; J R Schwebke
Journal:  Curr Infect Dis Rep       Date:  2013-04       Impact factor: 3.725

8.  Preferred characteristics of vaginal microbicides in women with bacterial vaginosis.

Authors:  Robert L Cook; Julie S Downs; Jeanne Marrazzo; Galen E Switzer; Ozlem Tanriover; Harold Wiesenfeld; Pamela J Murray; Sharon L Hillier
Journal:  J Womens Health (Larchmt)       Date:  2009-08       Impact factor: 2.681

9.  Dendritic cell activation and maturation induced by mucosal fluid from women with bacterial vaginosis.

Authors:  Elizabeth P St John; Jeff Martinson; Jose A Simoes; Alan L Landay; Gregory T Spear
Journal:  Clin Immunol       Date:  2007-07-24       Impact factor: 3.969

10.  Effect of mucosal fluid from women with bacterial vaginosis on HIV trans-infection mediated by dendritic cells.

Authors:  Elizabeth P St John; M Reza Zariffard; Jeffrey A Martinson; Jose A Simoes; Alan L Landay; Gregory T Spear
Journal:  Virology       Date:  2008-12-30       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.